Atorvastatin and Aspirin as Adjuvant Therapy in Patients with SARS-CoV-2 Infection: A structured summary of a study protocol for a randomised controlled trial

Peer Review reports

Original Submission
19 Oct 2020	Submitted	Original manuscript
21 Oct 2020	Reviewed	Reviewer Report - Kirsty Loudon
Resubmission - Version 2
	Submitted	Manuscript version 2
Publishing
22 Oct 2020	Editorially accepted
30 Oct 2020	Article published	10.1186/s13063-020-04840-y

Back to article page